629 related articles for article (PubMed ID: 18271917)
1. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
2. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
3. EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments.
Kataoka H
J Dermatol Sci; 2009 Dec; 56(3):148-53. PubMed ID: 19896805
[TBL] [Abstract][Full Text] [Related]
4. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
6. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
8. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
9. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
11. Urea signalling to immediate-early gene transcription in renal medullary cells requires transactivation of the epidermal growth factor receptor.
Zhao H; Tian W; Xu H; Cohen DM
Biochem J; 2003 Mar; 370(Pt 2):479-87. PubMed ID: 12466022
[TBL] [Abstract][Full Text] [Related]
12. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
[TBL] [Abstract][Full Text] [Related]
13. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
Itoh Y; Joh T; Tanida S; Sasaki M; Kataoka H; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Kubota H; Mori Y; Ohara H; Nomura T; Higashiyama S; Itoh M
Cytokine; 2005 Mar; 29(6):275-82. PubMed ID: 15749028
[TBL] [Abstract][Full Text] [Related]
14. Intranuclear translocation signaling of HB-EGF carboxy-terminal fragment and mucosal defense through cell proliferation and migration in digestive tracts.
Tanida S; Kataoka H; Mizoshita T; Shimura T; Kamiya T; Joh T
Digestion; 2010; 82(3):145-9. PubMed ID: 20588025
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor.
Witters L; Scherle P; Friedman S; Fridman J; Caulder E; Newton R; Lipton A
Cancer Res; 2008 Sep; 68(17):7083-9. PubMed ID: 18757423
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between the calcium-sensing receptor and the epidermal growth factor receptor in Rat-1 fibroblasts.
Tomlins SA; Bolllinger N; Creim J; Rodland KD
Exp Cell Res; 2005 Aug; 308(2):439-45. PubMed ID: 15950968
[TBL] [Abstract][Full Text] [Related]
17. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor signal transactivation.
Leserer M; Gschwind A; Ullrich A
IUBMB Life; 2000 May; 49(5):405-9. PubMed ID: 10902572
[TBL] [Abstract][Full Text] [Related]
19. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.
Krieg T; Cui L; Qin Q; Cohen MV; Downey JM
J Mol Cell Cardiol; 2004 Mar; 36(3):435-43. PubMed ID: 15010282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
